PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

va-Q-tec Opens New North American Headquarters and Operating Facility in Langhorne, PA

va-Q-tec, a leading provider of thermal packaging solutions for temperature controlled transportation, further expands its international presence with a new North American Headquarters and operations facility in Langhorne, PA. va-Q-tec invested several million USD in the 20,000 square foot facility and the U.S. market expansion. The new site will become the U.S. welcome and innovation center and showcase va-Q-tec’s latest products. In addition, va-Q-tec will also manufacture its small box containers in Langhorne and will use the location as a key hub for its rental and repair station. The facility has the capacity to produce 2,000 boxes and 50-100 containers per week.
va-Q-tec’s CEO Dr. Joachim Kuhn said, “The investment in this new facility is a testament to our commitment to grow the business and expand our footprint in North America. After careful consideration, Langhorne, PA is the perfect location for us — right in the heart of the healthcare cluster, close to several major airport hubs and with easy access to major roads across the country and in close proximity to the pharmaceutical centers in Boston and Durham, NC.”
Christopher J. Storch, Head of Global Sales added, “We want to offer our current and future customers the best solutions for their temperature controlled logistics needs. By opening the new facility, we are not only strengthening our position in the U.S., it also puts us in a better place to accompany the growth of the pharmaceutical industry, in which 27 of the top 50 best-selling pharmaceutical products will require temperature controlled transportation and handling by 2020.  Also as part of our growing local presence, Sandy Richwalski joined the company as Managing Director North America to better serve va-Q-tec’s growing U.S. customer base with a mid-term plan to hire 15 – 20 employees to service the business.”
va-Q-tec has been pioneering the thermal insulation industry for more than a decade. As the global market demands reliable logistics and packaging in a perfected temperature controlled environment, va-Q-tec’s vacuum insulation panels (“VIPs”) and phase change materials (“PCMs”) offer more effective and sustainable solutions for a global customer base. va-Q-tec’s advanced passive technology keeps the inside temperature of its packaging solutions constant for  five days or more without the need for additional external energy sources. Currently, there is no other controlled and proven system out there that can reach this level of performance without external sources.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026